PL4139474T3 - Kompozycje do kontroli diagnostycznej - Google Patents
Kompozycje do kontroli diagnostycznejInfo
- Publication number
- PL4139474T3 PL4139474T3 PL21721995.5T PL21721995T PL4139474T3 PL 4139474 T3 PL4139474 T3 PL 4139474T3 PL 21721995 T PL21721995 T PL 21721995T PL 4139474 T3 PL4139474 T3 PL 4139474T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- diagnostic control
- diagnostic
- control
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2522/00—Reaction characterised by the use of non-enzymatic proteins
- C12Q2522/10—Nucleic acid binding proteins
- C12Q2522/101—Single or double stranded nucleic acid binding proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/143—Modifications characterised by incorporating a promoter sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2545/00—Reactions characterised by their quantitative nature
- C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
- C12Q2545/113—Reactions characterised by their quantitative nature the purpose being quantitative analysis with an external standard/control, i.e. control reaction is separated from the test/target reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2005985.3A GB2594317B (en) | 2020-04-23 | 2020-04-23 | SARS-CoV-2 Diagnostic control compositions |
| PCT/IB2021/053369 WO2021214724A1 (en) | 2020-04-23 | 2021-04-23 | Diagnostic control compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4139474T3 true PL4139474T3 (pl) | 2025-05-26 |
Family
ID=71080166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21721995.5T PL4139474T3 (pl) | 2020-04-23 | 2021-04-23 | Kompozycje do kontroli diagnostycznej |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11713491B2 (pl) |
| EP (1) | EP4139474B1 (pl) |
| JP (1) | JP7349763B2 (pl) |
| CN (1) | CN116075595B (pl) |
| ES (1) | ES3018291T3 (pl) |
| GB (1) | GB2594317B (pl) |
| PL (1) | PL4139474T3 (pl) |
| WO (1) | WO2021214724A1 (pl) |
| ZA (1) | ZA202211845B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240279751A1 (en) * | 2020-06-10 | 2024-08-22 | King Abdullah University Of Science And Technology | A rapid multiplex rpa based nanopore sequencing method for real-time detection and sequencing of multiple viral pathogens |
| CN111793651A (zh) * | 2020-07-17 | 2020-10-20 | 广东源心再生医学有限公司 | 用于covid-19药物筛选的慢病毒表达载体及其构建方法 |
| CN114107309B (zh) * | 2021-11-19 | 2023-07-25 | 江南大学 | 一种非天然茶碱rna分子开关 |
| JP2025529099A (ja) * | 2022-09-02 | 2025-09-04 | ジェン－プローブ・インコーポレーテッド | サンプル中のウイルス病原体を検出するための組成物および方法 |
| WO2025007075A1 (en) * | 2023-06-29 | 2025-01-02 | Life Technologies Corporation | Molecules resistant to nuclease digestion |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0887405A1 (en) * | 1997-06-25 | 1998-12-30 | Gene Shears Pty Limited | Process for producing stabilised RNA molecules within cells, RNA molecules thus produced and nucleic acid precursors of such molecules |
| AU2003223244A1 (en) * | 2002-03-11 | 2003-09-29 | The Johns Hopkins University | Molecular switches and methods for making and using the same |
| CN1587420A (zh) * | 2004-07-20 | 2005-03-02 | 卫生部北京医院 | 内含rna病毒核酸的病毒样颗粒及其制备方法与应用 |
| US8080645B2 (en) * | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US20110206673A1 (en) * | 2007-06-27 | 2011-08-25 | Liu Dongxu | Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
| EP2252708B1 (en) * | 2008-03-20 | 2013-11-06 | Siemens Healthcare Diagnostics Inc. | Non-competitive internal controls for use in nucleic acid tests |
| CN102199674A (zh) | 2011-03-17 | 2011-09-28 | 中国疾病预防控制中心病毒病预防控制所 | 一种有包膜rna病毒核酸检测参照品/标准品平台及其应用方法 |
| WO2017060662A1 (en) | 2015-10-07 | 2017-04-13 | The Secretary Of State For Health | Method for providing a control for use in a screen for pathogenic virus |
| US10689689B2 (en) * | 2015-12-28 | 2020-06-23 | Roche Molecular Systems, Inc. | Generic method for the stabilization of specific RNA |
| JP2022529035A (ja) * | 2019-04-16 | 2022-06-16 | ジェンフィット | マイクロｒｎａの安定化のための組成物及び方法 |
| DE202020105116U1 (de) * | 2020-02-20 | 2020-10-06 | Charité - Universitätsmedizin Berlin | Reagenzien und Verwendungen zur Diagnose einer SARS-CoV-2-Infektion |
| US10689716B1 (en) * | 2020-03-19 | 2020-06-23 | University Of Miami | Materials and methods for detecting coronavirus |
-
2020
- 2020-04-23 GB GB2005985.3A patent/GB2594317B/en active Active
-
2021
- 2021-04-23 WO PCT/IB2021/053369 patent/WO2021214724A1/en not_active Ceased
- 2021-04-23 PL PL21721995.5T patent/PL4139474T3/pl unknown
- 2021-04-23 EP EP21721995.5A patent/EP4139474B1/en active Active
- 2021-04-23 ES ES21721995T patent/ES3018291T3/es active Active
- 2021-04-23 CN CN202180040343.9A patent/CN116075595B/zh active Active
- 2021-04-23 JP JP2022564441A patent/JP7349763B2/ja active Active
- 2021-04-23 US US17/996,919 patent/US11713491B2/en active Active
-
2022
- 2022-10-31 ZA ZA2022/11845A patent/ZA202211845B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230127238A1 (en) | 2023-04-27 |
| GB202005985D0 (en) | 2020-06-10 |
| JP2023515269A (ja) | 2023-04-12 |
| EP4139474C0 (en) | 2025-01-01 |
| EP4139474A1 (en) | 2023-03-01 |
| GB2594317A (en) | 2021-10-27 |
| WO2021214724A1 (en) | 2021-10-28 |
| ES3018291T3 (en) | 2025-05-14 |
| GB2594317B (en) | 2022-05-25 |
| US11713491B2 (en) | 2023-08-01 |
| EP4139474B1 (en) | 2025-01-01 |
| ZA202211845B (en) | 2025-02-26 |
| JP7349763B2 (ja) | 2023-09-25 |
| CN116075595B (zh) | 2025-09-16 |
| CN116075595A (zh) | 2023-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL4139474T3 (pl) | Kompozycje do kontroli diagnostycznej | |
| EP4227390A4 (en) | COMPOSITION CONTAINING A REFRIGERANT FLUID | |
| EP4148096A4 (en) | COMPOSITION | |
| EP4094582A4 (en) | COMPOSITION | |
| DK3924443T3 (da) | Compositions | |
| EP4328279A4 (en) | COMPOSITION | |
| EP4115893A4 (en) | Anti-tumor composition | |
| EP4279545A4 (en) | COMPOSITION | |
| EP4313320A4 (en) | ANTIPERSPIRANT COMPOSITION | |
| EP4291295A4 (en) | Intra-stimulus recruitment control | |
| EP3999039A4 (en) | PRETOMANID COMPOSITIONS | |
| EP4240781A4 (en) | pH-sensitive therapeutic compositions | |
| EP3996511A4 (en) | MICROBIAL COMPOSITIONS | |
| EP4372077A4 (en) | AUTOPHAGY-ACTIVATING COMPOSITION | |
| EP4337752C0 (en) | COMPOSITION | |
| EP4281046C0 (en) | NALTREXONE-BASED COMPOSITIONS | |
| EP4256012C0 (en) | COMPOSITION | |
| EP4291042C0 (en) | COMPOSITION DERIVED FROM OATS | |
| EP3806107C0 (en) | DIAGNOSTIC TOOL | |
| EP4454715A4 (en) | COMPOSITION | |
| EP4403170A4 (en) | COMPOSITION CONTAINING CARYOPHYLLENE | |
| EP4393305A4 (en) | COMPOSITION | |
| EP4330366C0 (en) | COMPOSITION | |
| EP4223850A4 (en) | COMPOSITION | |
| EP4317381A4 (en) | Grease composition |